These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Analysis of naturally acquired antibody responses to the 19-kd C-terminal region of merozoite surface protein-1 of Plasmodium vivax from individuals in Sanliurfa, Turkey. Zeyrek FY, Babaoglu A, Demirel S, Erdogan DD, Ak M, Korkmaz M, Coban C. Am J Trop Med Hyg; 2008 May; 78(5):729-32. PubMed ID: 18458304 [Abstract] [Full Text] [Related]
3. IgG subclasses pattern and high-avidity antibody to the C-terminal region of merozoite surface protein 1 of Plasmodium vivax in an unstable hypoendemic region in Iran. Mehrizi AA, Zakeri S, Salmanian AH, Sanati MH, Djadid ND. Acta Trop; 2009 Oct; 112(1):1-7. PubMed ID: 19481997 [Abstract] [Full Text] [Related]
7. IgG antibody profile to c-terminal region of Plasmodium vivax merozoite surface protein-1 in Thai individuals exposed to malaria. Pitabut N, Panichakorn J, Mahakunkijcharoen Y, Hirunpetcharat C, Looareesuwan S, Khusmith S. Southeast Asian J Trop Med Public Health; 2007 Jan; 38(1):1-7. PubMed ID: 17539238 [Abstract] [Full Text] [Related]
10. Naturally acquired immunity and reduced susceptibility to falciparum malaria in two subpopulations of endemic eastern India. Biswas S, Seth RK, Tyagi PK, Sharma SK, Dash AP. Scand J Immunol; 2008 Feb; 67(2):177-84. PubMed ID: 18086262 [Abstract] [Full Text] [Related]
11. Antibody response of naturally infected individuals to recombinant Plasmodium vivax apical membrane antigen-1. Rodrigues MH, Rodrigues KM, Oliveira TR, Cômodo AN, Rodrigues MM, Kocken CH, Thomas AW, Soares IS. Int J Parasitol; 2005 Feb; 35(2):185-92. PubMed ID: 15710439 [Abstract] [Full Text] [Related]
12. Resistance to chloroquine by Plasmodium vivax at Alor in the Lesser Sundas Archipelago in eastern Indonesia. Sutanto I, Suprijanto S, Nurhayati, Manoempil P, Baird JK. Am J Trop Med Hyg; 2009 Aug; 81(2):338-42. PubMed ID: 19635895 [Abstract] [Full Text] [Related]
13. Endemic coastal malaria in the Thousand Islands District, near Jakarta, Indonesia. Maguire JD, Tuti S, Sismadi P, Wiady I, Basri H, Krisin, Masbar S, Projodipuro P, Elyazar IR, Corwin AL, Bangs MJ. Trop Med Int Health; 2005 May; 10(5):489-96. PubMed ID: 15860097 [Abstract] [Full Text] [Related]
14. Acquisition of invasion-inhibitory antibodies specific for the 19-kDa fragment of merozoite surface protein 1 in a transmigrant population requires multiple infections. Murhandarwati EE, Black CG, Wang L, Weisman S, Koning-Ward TF, Baird JK, Tjitra E, Richie TL, Crabb BS, Coppel RL. J Infect Dis; 2008 Oct 15; 198(8):1212-8. PubMed ID: 18717639 [Abstract] [Full Text] [Related]
17. Plasmodium vivax malaria in Sri Lanka: transmission, disease and immunity. Carter R, David P, Mendis K. Parassitologia; 1993 Jul 15; 35 Suppl():17-8. PubMed ID: 8233604 [Abstract] [Full Text] [Related]
18. Malaria epidemiology in low-endemicity areas of the Atlantic Forest in the Vale do Ribeira, São Paulo, Brazil. Curado I, Dos Santos Malafronte R, de Castro Duarte AM, Kirchgatter K, Branquinho MS, Bianchi Galati EA. Acta Trop; 2006 Nov 15; 100(1-2):54-62. PubMed ID: 17126279 [Abstract] [Full Text] [Related]
19. Evidence for the transmission of Plasmodium vivax in the Republic of the Congo, West Central Africa. Culleton R, Ndounga M, Zeyrek FY, Coban C, Casimiro PN, Takeo S, Tsuboi T, Yadava A, Carter R, Tanabe K. J Infect Dis; 2009 Nov 01; 200(9):1465-9. PubMed ID: 19803728 [Abstract] [Full Text] [Related]
20. High levels of IgG3 anti ICB2-5 in Plasmodium vivax-infected individuals who did not develop symptoms. Versiani FG, Almeida ME, Melo GC, Versiani FO, Orlandi PP, Mariúba LA, Soares LA, Souza LP, da Silva Balieiro AA, Monteiro WM, Costa FT, del Portillo HA, Lacerda MV, Nogueira PA. Malar J; 2013 Aug 27; 12():294. PubMed ID: 23977965 [Abstract] [Full Text] [Related] Page: [Next] [New Search]